Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on AZD1775 PK in Advanced Solid Tumours
NCT03315091Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 1, randomised, open-label trial of adavosertib in solid tumor (2 arms), sponsored by AstraZeneca. Primary endpoints: Area under the plasma concentration-time curve from zero to infinity, Area under the plasma concentration-time curve from time zero to the last quantifiable concentration and 1 more. Started Sep 2017; status: completed.
02
Drugs
adavosertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03315091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315091.